Table 1.
Demographics and baseline characteristics of patients with COVID-19.
| All patient (n = 218) | Asymptomatic cases (n = 24) | Mild cases (n = 10) | Moderate cases (n = 146) | Severe cases (n = 24) | Critical cases (n = 14) | P-value | |
|---|---|---|---|---|---|---|---|
| Age, years | 42.9 (32.0–52.3) | 32.0 (16.3–44.8)c, d, e | 23.6 (11.8–34.3)c, d, e | 42.3 (32.0–50.0)a, b, d, e | 55.9 (46.3–67.0)a, b, c | 59.5 (42.3–76.5)a, b, c | 0.000* |
| Age range, years | |||||||
| 0–17 | 14 (6%) | 6 (25%) | 4 (40%) | 4 (3%) | 0 | 0 | 0.000** |
| 18–39 | 82 (38%) | 11 (46%) | 5 (50%) | 60 (41%) | 4 (17%) | 2 (14%) | |
| 40–59 | 86 (39%) | 6 (25%) | 1 (10%) | 65 (45%) | 9 (37%) | 5 (36%) | |
| 60–79 | 30 (14%) | 1 (4%) | 0 | 15 (10%) | 10 (42%) | 4 (29%) | |
| ≥80 | 6 (3%) | 0 | 0 | 2 (1%) | 1 (4%) | 3 (21%) | |
| Sex | |||||||
| Male | 122 (56%) | 16 (67%) | 6 (60%) | 77 (53%) | 14 (58%) | 9 (64%) | 0.691 |
| Female | 96 (44%) | 8 (33%) | 4 (40%) | 69 (47%) | 10 (42%) | 5 (36%) | |
| Exposure | |||||||
| Exposure to Wuhan | 111 (51%) | 12 (50%) | 3 (30%) | 76 (52%) | 13 (54%) | 7 (50%) | 0.768 |
| Exposure to patients† | 100 (46%) | 18 (75%) | 7 (70%) | 59 (40%) | 8 (33%) | 8 (57%) | 0.006** |
| Use of public transportation‡ | 4 (2 %) | 0 | 0 (%) | 3 (2%) | 0 | 1 (7%) | 0.535 |
| Current smoking | 23 (11%) | 2 (8%) | 2 (20%) | 14 (10%) | 3 (13%) | 2 (14%) | 0.902 |
| Chronic medical illness | |||||||
| Cardiovascular disease | 38 (17%) | 3 (13%) | 0 | 17 (12%) | 13 (54%) | 5 (36%) | 0.000** |
| Diabetes | 27 (12%) | 3 (13%) | 0 | 12 (8%) | 10 (42%) | 2 (14%) | 0.001** |
| Chronic pulmonary disease | 14 (6%) | 0 | 0 | 5 (3%) | 4 (17%) | 5 (36%) | 0.000** |
| Liver disease | 13 (6%) | 1 (4%) | 0 | 10 (7%) | 2 (8%) | 0 | 0.909 |
| Malnutrition§ | 10 (5%) | 0 | 1 (10%) | 6 (4%) | 1 (4%) | 2 (14%) | 0.193 |
| Cerebrovascular disease | 6 (3%) | 0 | 0 | 2 (1%) | 1 (4%) | 3 (21%) | 0.014** |
| Chronic renal diseases | 4 (2%) | 0 | 0 | 1 (1%) | 1 (4%) | 2 (14%) | 0.031** |
| Cancer | 2 (1%) | 0 | 0 | 2 (1%) | 0 | 0 | 1.000 |
| Autoimmune disease | 2 (1%) | 0 | 0 | 1 (1%) | 0 | 1 (7%) | 0.256 |
Data are median (IQR), n (%), or mean (SD), unless otherwise specified.
*
ANOVA was used for group comparisons with LSD for post-hoc tests.
avs. Asymptomatic cases (p < 0.05), bvs. Mild cases (p < 0.05), cvs. Moderate cases (p < 0.05), dvs. Severe cases (p < 0.05), evs. Critical cases (p < 0.05).
**
Statistical analysis was performed with the chi-square test or Fisher's exact test.
†
Patients who have confirmed SARS-CoV-2 infection or are highly suspected of being infected.
‡
Without exposure to Wuhan and diagnosed patients.
§
In this cohort, 3 patients suffer from undernutrition and 7 are overweight.